{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:04:24Z","timestamp":1779858264671,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0521800"],"award-info":[{"award-number":["2024ZD0521800"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2023YFA1800700"],"award-info":[{"award-number":["2023YFA1800700"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2024YFC3044500"],"award-info":[{"award-number":["2024YFC3044500"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","award":["ZY202205SMKY002"],"award-info":[{"award-number":["ZY202205SMKY002"]}],"id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430013"],"award-info":[{"award-number":["82430013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82225004"],"award-info":[{"award-number":["82225004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370240"],"award-info":[{"award-number":["82370240"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["226\\u20132023-00156"],"award-info":[{"award-number":["226\\u20132023-00156"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.yjmcc.2025.07.018","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T09:33:14Z","timestamp":1754127194000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["FMO2 expression confers cardioprotection in doxorubicin therapy while preserving antitumor activity"],"prefix":"10.1016","volume":"207","author":[{"given":"Shuyuan","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianpeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changle","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2025.07.018_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115612","article-title":"Doxorubicin prodrug-based nanomedicines for the treatment of cancer","volume":"258","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.yjmcc.2025.07.018_bb0010","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1200\/JCO.23.02763","article-title":"Doxorubicin and breast Cancer risk: the importance of long-term follow-up in curable cancers","volume":"42","author":"Radford","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.07.018_bb0015","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood.2024024681","article-title":"Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma","volume":"145","author":"Lee","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.yjmcc.2025.07.018_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101205","article-title":"Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming","volume":"93","author":"Mattioli","year":"2023","journal-title":"Mol. Asp. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.07.018_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41514-024-00135-7","article-title":"A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging","volume":"10","author":"Linders","year":"2024","journal-title":"NPJ Aging."},{"key":"10.1016\/j.yjmcc.2025.07.018_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2023.02.019","article-title":"Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?","volume":"185","author":"Dempke","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yjmcc.2025.07.018_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.yjmcc.2025.07.018_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121739","article-title":"Safety evaluation of the combination with Dexrazoxane and anthracyclines: a disproportionality analysis based on the Food and Drug Administration adverse event reporting system database","volume":"17","author":"Liu","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.yjmcc.2025.07.018_bb0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1200\/JCO.2005.02.3879","article-title":"Dexrazoxane-associated risk for acute myeloid leukemia\/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin\u2019s disease","volume":"25","author":"Tebbi","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.07.018_bb0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41419-022-04783-z","article-title":"Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.07.018_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13768","article-title":"DNA repair in cardiomyocytes is critical for maintaining cardiac function in mice","volume":"22","author":"de Boer","year":"2023","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.yjmcc.2025.07.018_bb0060","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.stemcr.2022.03.002","article-title":"RARG S427L attenuates the DNA repair response to doxorubicin in induced pluripotent stem cell-derived cardiomyocytes","volume":"17","author":"Huang","year":"2022","journal-title":"Stem Cell Rep."},{"issue":"47","key":"10.1016\/j.yjmcc.2025.07.018_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309200120","article-title":"Impaired end joining induces cardiac atrophy in a Hutchinson-Gilford progeria mouse model","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.yjmcc.2025.07.018_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6218","key":"10.1016\/j.yjmcc.2025.07.018_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1126\/science.1261971","article-title":"DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair","volume":"347","author":"Ochi","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.07.018_bb0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/17425255.2017.1239718","article-title":"Drug metabolism by flavin-containing monooxygenases of human and mouse","volume":"13","author":"Phillips","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.07.018_bb0085","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1124\/dmd.116.070169","article-title":"Going beyond common drug metabolizing enzymes: case studies of biotransformation involving aldehyde oxidase, gamma-Glutamyl Transpeptidase, Cathepsin B, Flavin-containing monooxygenase, and ADP-Ribosyltransferase","volume":"44","author":"Fan","year":"2016","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.07.018_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400029","article-title":"Flavin-containing monooxygenase (FMO): beyond xenobiotics","volume":"46","author":"Bhat","year":"2024","journal-title":"Bioessays"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.07.018_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.122.320538","article-title":"Flavin containing monooxygenase 2 prevents cardiac fibrosis via CYP2J3-SMURF2 Axis","volume":"131","author":"Ni","year":"2022","journal-title":"Circ. Res"},{"issue":"12","key":"10.1016\/j.yjmcc.2025.07.018_bb0100","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJMcibr1214975","article-title":"Anthracyclines and heart failure","volume":"368","author":"Sawyer","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.07.018_bb0105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"gammaH2AX: a sensitive molecular marker of DNA damage and repair","volume":"24","author":"Mah","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.yjmcc.2025.07.018_bb0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/em.21944","article-title":"DNA damage foci: meaning and significance","volume":"56","author":"Rothkamm","year":"2015","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.yjmcc.2025.07.018_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107165","article-title":"Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42","volume":"203","author":"Kucuk","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.07.018_bb0120","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.molcel.2015.01.005","article-title":"Akt-mediated phosphorylation of XLF impairs non-homologous end-joining DNA repair","volume":"57","author":"Liu","year":"2015","journal-title":"Mol. Cell"},{"issue":"15","key":"10.1016\/j.yjmcc.2025.07.018_bb0125","doi-asserted-by":"crossref","first-page":"11155","DOI":"10.1074\/jbc.M609904200","article-title":"Length-dependent binding of human XLF to DNA and stimulation of XRCC4.DNA ligase IV activity","volume":"282","author":"Lu","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.07.018_bb0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cell.2005.12.031","article-title":"XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining","volume":"124","author":"Ahnesorg","year":"2006","journal-title":"Cell"},{"issue":"W1","key":"10.1016\/j.yjmcc.2025.07.018_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.07.018_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac558","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"Liu","year":"2023","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.yjmcc.2025.07.018_bb0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.03.016","article-title":"Doxorubicin targets multiple players: a new view of an old problem","volume":"127","author":"Cappetta","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yjmcc.2025.07.018_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105062","article-title":"Cardiotoxicity of doxorubicin-based cancer treatment: what is the protective cognition that phytochemicals provide us?","volume":"160","author":"Liu","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.07.018_bb0155","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.yjmcc.2009.07.024","article-title":"Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity","volume":"47","author":"Yoshida","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.07.018_bb0160","article-title":"Role of paralogue of XRCC4 and XLF in DNA damage repair and Cancer development","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.07.018_bb0165","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1038\/s41598-023-40061-4","article-title":"Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial","volume":"13","author":"Osataphan","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.07.018_bb0170","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/cvr\/cvae084","article-title":"Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy","volume":"120","author":"Chen","year":"2024","journal-title":"Cardiovasc. Res."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282825001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282825001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:45:39Z","timestamp":1779857139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282825001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"alternative-id":["S0022282825001415"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2025.07.018","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FMO2 expression confers cardioprotection in doxorubicin therapy while preserving antitumor activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2025.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}